GENERAL6 Sept 2026
India moves to block new nicotine pouch formulations amid addiction risks | Mint
India's tobacco control body has asked the drug advisory board to reject licences for new nicotine pouches in 2mg, 4mg and 6mg strengths. These small flavoured sachets, placed between gum and lip, are marketed as tobacco-free quitting aids. Officials warn they are addictive, harm health, and may attract youth. They want proven quit methods instead. Manufacturers and importers face hurdles.
Key Statutory Highlights
- India's tobacco control body recommended rejecting licence applications for nicotine pouches in 2mg, 4mg and 6mg strengths.
- Health officials say nicotine pouches are addictive, carry independent health risks, and are not effective cessation aids.
- The health ministry wants evidence-based cessation methods prioritised over these new nicotine formulations.
Actionable Advice for Taxpayers / Founders:Manufacturers and importers of nicotine pouches should monitor upcoming drug advisory board decisions before chasing new licences.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: